These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20621008)
21. Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design. Oppegaard KS; Nesheim BI; Istre O; Qvigstad E BJOG; 2007 Jun; 114(6):769, e1-12. PubMed ID: 17516971 [TBL] [Abstract][Full Text] [Related]
22. Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol. Darwish AM; Ahmad AM; Mohammad AM Hum Reprod; 2004 Oct; 19(10):2391-4. PubMed ID: 15333607 [TBL] [Abstract][Full Text] [Related]
24. Vaginal misoprostol for cervical priming prior to diagnostic hysteroscopy--efficacy, safety and patient satisfaction: a randomized controlled trial. Singh N; Ghosh B; Naha M; Mittal S Arch Gynecol Obstet; 2009 Jan; 279(1):37-40. PubMed ID: 18449549 [TBL] [Abstract][Full Text] [Related]
25. Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction. Cecatti JG; Tedesco RP; Pires HM; Calderon IM; Faúndes A Acta Obstet Gynecol Scand; 2006; 85(6):706-11. PubMed ID: 16752263 [TBL] [Abstract][Full Text] [Related]
26. Misoprostol for cervical ripening and labor induction. Votipka JR J Fam Pract; 1997 Jul; 45(1):20. PubMed ID: 9228905 [No Abstract] [Full Text] [Related]
27. Misoprostol for cervical ripening prior to gynecological transcervical procedures. Ghosh A; Chaudhuri P Arch Gynecol Obstet; 2013 May; 287(5):967-73. PubMed ID: 23241727 [TBL] [Abstract][Full Text] [Related]
28. Misoprostol induces cervical nitric oxide release in pregnant, but not in nonpregnant, women. Väisänen-Tommiska M; Mikkola TS; Ylikorkala O Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):790-6. PubMed ID: 16150276 [TBL] [Abstract][Full Text] [Related]
29. Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysis. Polyzos NP; Zavos A; Valachis A; Dragamestianos C; Blockeel C; Stoop D; Papanikolaou EG; Tournaye H; Devroey P; Messinis IE Hum Reprod Update; 2012 Jul; 18(4):393-404. PubMed ID: 22544173 [TBL] [Abstract][Full Text] [Related]
30. Methods for cervical ripening and induction of labor. Tenore JL Am Fam Physician; 2003 May; 67(10):2123-8. PubMed ID: 12776961 [TBL] [Abstract][Full Text] [Related]
31. Priming effect of misoprostol on estrogen pretreated cervix in postmenopausal women. Atmaca R; Kafkasli A; Burak F; Germen AT Tohoku J Exp Med; 2005 Jul; 206(3):237-41. PubMed ID: 15942151 [TBL] [Abstract][Full Text] [Related]
32. Vaginal misoprostol for cervical ripening prior to hysteroscopy. Burch D; Avasarala S BJOG; 2008 Dec; 115(13):1720; author reply 1720-1. PubMed ID: 19035958 [No Abstract] [Full Text] [Related]
33. Use of Oral Misoprostol for Cervical Priming before Hysteroscopy: A Randomized Comparison of Two Dosages. Kesrouani A; Maalouf S; Mansour F; Attieh E Gynecol Obstet Invest; 2016; 81(4):333-8. PubMed ID: 26588025 [TBL] [Abstract][Full Text] [Related]
34. Misoprostol for cervical ripening in non-pregnant women: a randomized double-blind controlled trial of oral versus vaginal regimens. Choksuchat C; Cheewadhanaraks S; Getpook C; Wootipoom V; Dhanavoravibul K Hum Reprod; 2006 Aug; 21(8):2167-70. PubMed ID: 16585121 [TBL] [Abstract][Full Text] [Related]
35. A randomised trial of oral misoprostol in premenopausal women before hysteroscopy. Healey S; Crane JMG J Obstet Gynaecol Can; 2007 Dec; 29(12):973-974. PubMed ID: 18193503 [No Abstract] [Full Text] [Related]
36. [Preparation of Cervical Dilatation Before with Misoprostol and Laminaria - Advantages and Disadvantages.]. Angelova M; Kovachev E; Miteva K; Atanasova Z Akush Ginekol (Sofiia); 2016; 55(6):10-15. PubMed ID: 29370500 [TBL] [Abstract][Full Text] [Related]
37. Vaginal misoprostol prior to diagnostic hysteroscopy in patients of reproductive age: a randomized clinical trial. Valente EP; de Amorim MM; Costa AA; de Miranda DV J Minim Invasive Gynecol; 2008; 15(4):452-8. PubMed ID: 18539093 [TBL] [Abstract][Full Text] [Related]
38. The effects of the prostaglandin E analogue Misoprostol and follicle-stimulating hormone on cervical penetrability in ewes during the peri-ovulatory period. Leethongdee S; Khalid M; Bhatti A; Ponglowhapan S; Kershaw CM; Scaramuzzi RJ Theriogenology; 2007 Mar; 67(4):767-77. PubMed ID: 17126896 [TBL] [Abstract][Full Text] [Related]
39. Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and premenopausal nulliparous women; a multicentre randomised placebo controlled trial. Tasma ML; Louwerse MD; Hehenkamp WJ; Geomini PM; Bongers MY; Veersema S; van Kesteren PJ; Tromp E; Huirne JA; Graziosi GC BJOG; 2018 Jan; 125(1):81-89. PubMed ID: 28109045 [TBL] [Abstract][Full Text] [Related]
40. A randomized trial of oral misoprostol in premenopausal women before hysteroscopy. Healey S; Butler B; Kum FN; Dunne J; Hutchens D; Crane JM J Obstet Gynaecol Can; 2007 Aug; 29(8):648-52. PubMed ID: 17714618 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]